Onset of secondary progressive MS after long-term rituximab therapy - a case report
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Onset of secondary progressive MS after long-term rituximab therapy - a case report
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume 4, Issue 1, Pages 46-52
Publisher
Wiley
Online
2016-12-20
DOI
10.1002/acn3.377
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis
- (2015) Martina Absinta et al. NEUROLOGY
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Age, Gender and Normalization Covariates for Spinal Cord Gray Matter and Total Cross-Sectional Areas at Cervical and Thoracic Levels: A 2D Phase Sensitive Inversion Recovery Imaging Study
- (2015) Nico Papinutto et al. PLoS One
- Spinal cord gray matter atrophy correlates with multiple sclerosis disability
- (2014) Regina Schlaeger et al. ANNALS OF NEUROLOGY
- The Charcot Lecture | Beating MS: A story of B cells, with twists and turns
- (2014) Stephen L Hauser Multiple Sclerosis Journal
- Meningeal and cortical grey matter pathology in multiple sclerosis
- (2012) Bogdan F Gh Popescu et al. BMC Neurology
- Cortical lesion load associates with progression of disability in multiple sclerosis
- (2012) M. Calabrese et al. BRAIN
- B cell exchange across the blood-brain barrier in multiple sclerosis
- (2012) H.-Christian von Büdingen et al. JOURNAL OF CLINICAL INVESTIGATION
- The neuropathological basis of clinical progression in multiple sclerosis
- (2011) Richard Reynolds et al. ACTA NEUROPATHOLOGICA
- Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
- (2011) Douglas S Goodin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Gray matter atrophy is related to long-term disability in multiple sclerosis
- (2008) Leonora K. Fisniku et al. ANNALS OF NEUROLOGY
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now